Cytosorbents (CTSO) EBITDA Margin Growth (3y) (2014 - 2026)
Cytosorbents (CTSO) EBITDA Margin Growth (3y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | -201.00 |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 586.00 |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 78.00 |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 736.00 |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 887.00 |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 963.00 |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 212.00 |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 535.00 |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 244.00 |
| 10 | Cytosorbents | 23.26 Mn | 18.85 Mn | 7.05 Mn | 4,224.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4,224.00 |
| Mar 31, 2026 | 4,917.00 |
| Dec 31, 2025 | 2,020.00 |
| Sep 30, 2025 | 8,100.00 |
| Jun 30, 2025 | 6,078.00 |
| Mar 31, 2025 | 4,509.00 |
| Dec 31, 2024 | 5,158.00 |
| Sep 30, 2024 | -69.00 |
| Jun 30, 2024 | 58.00 |
| Mar 31, 2024 | -2,489.00 |
| Dec 31, 2023 | -8,650.00 |
| Sep 30, 2023 | -6,484.00 |
| Jun 30, 2023 | -3,596.00 |
| Mar 31, 2023 | -5,505.00 |
| Dec 31, 2022 | 541.00 |
| Sep 30, 2022 | -1,884.00 |
| Jun 30, 2022 | -4,013.00 |
| Mar 31, 2022 | -710.00 |
| Dec 31, 2021 | 317.00 |
| Sep 30, 2021 | -819.00 |